{"id":12533,"date":"2024-10-11T19:58:44","date_gmt":"2024-10-11T17:58:44","guid":{"rendered":"https:\/\/valintermed.com\/?p=12533"},"modified":"2024-10-11T19:58:44","modified_gmt":"2024-10-11T17:58:44","slug":"pervichnyy-t-kletochnyy-immunodefitsit","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/primary-cellular-immunodeficiency\/","title":{"rendered":"Primary T-cell immunodeficiency"},"content":{"rendered":"
<\/div>\n

Primary T-cell immunodeficiency (PTCID) is a group of inherited disorders characterized by abnormal functioning of T lymphocytes, resulting in significant vulnerability to infections and other diseases. T cells play a key role in the immune system's defense mechanisms, including cellular immune response, assisting in B-cell activation, and regulating immune responses. Patients with PTCID experience increased morbidity due to the body's inability to adequately respond to pathogens. This often leads to recurrent infections, autoimmune diseases, and even an increased risk of developing certain cancers. The incidence and severity of clinical symptoms may vary depending on the type of primary immunodeficiency.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n